You are here

Article info

Article menu
Download PDFPDF
Review
Bremelanotide and flibanserin for low sexual desire in women: the fallacy of regulatory precedent

Authors

  • Barbara Mintzes School of Pharmacy and Charles Perkins Centre, Faculty of Medicine and Health, The University of Sydney, Sydney, New South Wales, Australia School of Population and Public Health, University of British Columbia, Vancouver, British Columbia, Canada PubMed articlesGoogle scholar articles
  • Leonore Tiefer Department of Psychiatry, New York School of Medicine, New York, New York, USA PubMed articlesGoogle scholar articles
  • Lisa Cosgrove Counseling Psychology Department and Applied Ethics Center, University of Massachusetts Boston, Boston, Massachusetts, USA PubMed articlesGoogle scholar articles
  1. Correspondence to Dr Barbara Mintzes, School of Pharmacy and Charles Perkins Centre, The University of Sydney Faculty of Medicine and Health, Sydney, New South Wales, Australia; barbara.mintzes{at}sydney.edu.au
View Full Text

Citation

Mintzes B, Tiefer L, Cosgrove L
Bremelanotide and flibanserin for low sexual desire in women: the fallacy of regulatory precedent
Drug and Therapeutics Bulletin 2021;59:185-188.

Publication history

  • First published October 12, 2021.
Online issue publication 
November 25, 2021

Article Versions

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Copyright information

© Author(s) (or their employer(s)) 2021. No commercial re-use. See rights and permissions. Published by BMJ.